Raymond James & Associates’s Microvision MVIS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-11,639
Closed -$27.4K 3999
2022
Q4
$27.4K Sell
11,639
-291
-2% -$902 ﹤0.01% 3769
2022
Q3
$43K Sell
11,930
-50
-0.4% -$236 ﹤0.01% 3724
2022
Q2
$46K Buy
11,980
+50
+0.4% +$179 ﹤0.01% 3797
2022
Q1
$56K Buy
+11,930
New +$47K ﹤0.01% 3901
2018
Q1
Sell
-10,025
Closed -$16K 3540
2017
Q4
$16K Sell
10,025
-2,500
-20% -$4.81K ﹤0.01% 3356
2017
Q3
$35K Hold
12,525
﹤0.01% 3270
2017
Q2
$27K Buy
+12,525
New +$26.9K ﹤0.01% 3234

Other funds holding MVIS

Raymond James & Associates's MVIS Position: Q1 2023 in Review

Raymond James & Associates sold out of Microvision (MVIS) in Q1 2023, closing a stake of 11,639 shares — an estimated $27.4K sold.

Raymond James & Associates first reported a position in MVIS in Q2 2017 and held it in 7 quarters. The position peaked at $56K in Q1 2022. 148 funds tracked by Wall St. Rank hold MVIS as of Q1 2023.

  • Raymond James & Associates reported no remaining Microvision position as of Q1 2023 after selling out during the quarter.
  • Raymond James & Associates sold 11,639 Microvision shares in Q1 2023, an estimated $27.4K.
  • Raymond James & Associates first reported a position in Microvision in Q2 2017 and held it in 7 quarters.
  • Raymond James & Associates's Microvision position peaked at $56K in Q1 2022.
  • 148 funds tracked by Wall St. Rank held Microvision as of Q1 2023.

Based on Raymond James & Associates's 13F filing for Q1 2023, filed 14 Apr 2023.